Key points are not available for this paper at this time.
Randomized clinical trials have shown that sacubitril-valsartan reduces the risks of mortality and hospitalization in patients with heart failure with reduced ejection fraction (HFrEF), but patients with kidney failure requiring dialysis were excluded.
Building similarity graph...
Analyzing shared references across papers
Loading...
Dustin Le
Morgan E. Grams
Josef Coresh
JAMA Network Open
Johns Hopkins University
New York University
Building similarity graph...
Analyzing shared references across papers
Loading...
Le et al. (Tue,) studied this question.
synapsesocial.com/papers/68e5b8a1b6db6435875511b2 — DOI: https://doi.org/10.1001/jamanetworkopen.2024.29237